AstraZeneca Pharma India

L24231KA1979PLC003563 · ISIN — · 4 filings, FY 2022-23 to FY 2025-26 · standalone basis

Reclaimed at end of life

Tonnes as filed. Totals combine re-used, recycled and safely disposed, because filers place comparable activity in different columns.

reporting_boundary_changed. Reporting boundary changed across years: FY 2022-23 Standalone basis, FY 2023-24 Standalone, FY 2024-25 Standalone, FY 2025-26 Standalone. Year-on-year figures cover different entities.

reporting_boundary_changed. Reporting boundary changed across years: FY 2022-23 Standalone basis, FY 2023-24 Standalone, FY 2025-26 Standalone. Year-on-year figures cover different entities.

CategoryFY 2022-23FY 2023-24FY 2024-25FY 2025-26
Plastics including packaging not filednot filednot filednot filed
E-waste not filednot filednot filednot filed
Hazardous waste not filednot filednot filednot filed
Other waste not filednot filednot filednot filed
Total reclaimed 0000

NIC codes filed

Products and services accounting for 90 percent of turnover, latest filing.

CodeDescription as filedShare of turnover
477 Drugs and Pharmaceutical products 100.00%

Source filings

YearBasisTaxonomyTurnover as filed
FY 2022-23 Standalone basis 2023-06-30 10,02,97,07,540
FY 2023-24 Standalone 2024-04-30 12,95,52,62,091
FY 2024-25 Standalone 2025-05-31 17,16,29,16,656.6
FY 2025-26 Standalone 2026-02-28 22,75,57,76,133

Figures read from BRSR XBRL as filed. Nothing estimated or restated. How this works · Report an error